How have PKTX shares performed in 2024?

ProtoKinetix's stock was trading at $0.0190 at the beginning of the year. Since then, PKTX stock has decreased by 10.5% and is now trading at $0.0170. View the best growth stocks for 2024 here .

Are investors shorting ProtoKinetix?

ProtoKinetix saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 3,500 shares, a decrease of 31.4% from the March 15th total of 5,100 shares. Based on an average trading volume of 195,100 shares, the short-interest ratio is currently 0.0 days. View ProtoKinetix's Short Interest .

When is ProtoKinetix's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024. View our PKTX earnings forecast .

What other stocks do shareholders of ProtoKinetix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProtoKinetix investors own include Fulcrum Therapeutics (FULC) , Rockwell Medical (RMTI) , Provention Bio (PRVB) , VIVUS (VVUS) , Actinium Pharmaceuticals (ATNM) , Chimerix (CMRX) , Rexahn Pharmaceuticals (REXN) , SCYNEXIS (SCYX) and VBI Vaccines (VBIV) .

How do I buy shares of ProtoKinetix?

Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PKTX

ProtoKinetix (PKTX) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)

Free PKTX Stock Alerts

$0.02

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: $0.0170
▼
$0.0186
50-Day Range: $0.01
▼
$0.02
52-Week Range: $0.01
▼
$0.03

Volume: 10,510 shs
Average Volume: 145,292 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Get ProtoKinetix alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About ProtoKinetix Stock (OTCMKTS:PKTX)

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

PKTX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PKTX Stock News Headlines

April 16, 2024 | markets.businessinsider.com

Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying

April 9, 2024 | americanbankingnews.com

ProtoKinetix (OTCMKTS:PKTX) Shares Pass Below 50-Day Moving Average of $0.02

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

November 18, 2023 | finance.yahoo.com

ProtoKinetix, Incorporated (PKTX)

November 12, 2023 | morningstar.com

ProtoKinetix Inc PKTX

October 30, 2023 | benzinga.com

Insiders Buying ProtoKinetix And 2 Other Stocks Under $2

June 6, 2023 | finance.yahoo.com

Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication

October 10, 2022 | reuters.com

PKTX.PK - ProtoKinetix, Inc. | Stock Price & Latest News | Reuters

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

October 6, 2022 | benzinga.com

ProtoKinetix Stock (OTC:PKTX), Dividends

July 20, 2022 | tmcnet.com

ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants

July 17, 2022 | uk.investing.com

Around $12 Million Bet On Sonim Technologies? 4 Penny Stocks Insiders Are Buying

July 15, 2022 | insidermonkey.com

Hedge Fund and Insider Trading News: Alan Howard, Cathie Wood, Elliott Management, Bridgewater Associates, Sonim Technologies Inc (SONM), ProtoKinetix, Incorporated (PKTX), and More

January 14, 2022 | finance.yahoo.com

ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only

November 23, 2021 | finance.yahoo.com

ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease

August 9, 2021 | benzinga.com

4 Penny Stocks Insiders Are Buying

See More Headlines

Receive PKTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProtoKinetix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 4/29/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:PKTX
Previous Symbol: NASDAQ:PKTX
CUSIP: N/A
CIK: 1128189
Web: www.protokinetix.com
Phone: (330) 445-4971
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Clarence Edward Smith (Age 60)
Chairman, President & CEO
Mr. Michael Richard Guzzetta CPA (Age 66)
Chief Financial Officer
Comp: $60k

Key Competitors

View All Competitors

PKTX Stock Analysis - Frequently Asked Questions

How have PKTX shares performed in 2024?: ProtoKinetix's stock was trading at $0.0190 at the beginning of the year. Since then, PKTX stock has decreased by 10.5% and is now trading at $0.0170.
View the best growth stocks for 2024 here.
Are investors shorting ProtoKinetix?: ProtoKinetix saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 3,500 shares, a decrease of 31.4% from the March 15th total of 5,100 shares. Based on an average trading volume of 195,100 shares, the short-interest ratio is currently 0.0 days.
View ProtoKinetix's Short Interest.
When is ProtoKinetix's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, April 29th 2024.
View our PKTX earnings forecast.

What other stocks do shareholders of ProtoKinetix own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ProtoKinetix investors own include Fulcrum Therapeutics (FULC), Rockwell Medical (RMTI), Provention Bio (PRVB), VIVUS (VVUS), Actinium Pharmaceuticals (ATNM), Chimerix (CMRX), Rexahn Pharmaceuticals (REXN), SCYNEXIS (SCYX) and VBI Vaccines (VBIV).
How do I buy shares of ProtoKinetix?: Shares of PKTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PKTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial